engagement within the new system
TRANSCRIPT
![Page 1: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/1.jpg)
Engagement within the new systemPaul McManus, Lead Pharmacist | Specialised Commissioning
![Page 2: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/2.jpg)
Engagement within the new systemPaul McManusLead pharmacist - specialised servicesSouth Yorkshire and Bassetlaw Area Team
ABPI Regional event June 2013
![Page 3: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/3.jpg)
NHS | Presentation to [XXXX Company] | [Type Date]3
![Page 4: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/4.jpg)
Opportunities for engagement
Product specificNational
• research
• pipeline
• commissioning
• value
• price
• placement4
Local• implementation
• price
• priorities
• problems
![Page 5: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/5.jpg)
Medicines optimisation
Medicines still most common therapeutic intervention and biggest cost after staff,
but, for example:
•30 to 50% not taken as intended
•Patients have insufficient supporting information
• UK Literature suggests 5 to 8% of hospital admissions due to preventable adverse effects of medicines
•Medication errors across all sectors and age groups at unacceptable levels
•Medicines wastage in primary care: £300M pa with £150M pa avoidable
•Relatively little effort towards understanding clinical effectiveness of medicines in real practice
•The threat of antimicrobial resistance
Source: NHS Prescription Services of the NHS Business Service Authority
![Page 6: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/6.jpg)
National Reporting and Learning System for England and WalesTypes of incidents 2005-10
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
![Page 7: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/7.jpg)
NRLS in England and Wales medication incident reports 2005 - 10
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
![Page 8: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/8.jpg)
NRLS – who is reporting incidents?
8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
![Page 9: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/9.jpg)
NRLS – Critical medicines
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
NRLS – Critical medicines
![Page 10: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/10.jpg)
NRLS – Error category
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
![Page 11: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/11.jpg)
Medicines Optimisation Principles
![Page 12: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/12.jpg)
A strategy might include…• Patient engagement • Collaborative working across health economies• Improving outcomes• Value for money • Partnership with industry• Medicines pathway• Safety and assurance
12
Information and technology
![Page 13: Engagement within the new system](https://reader036.vdocuments.us/reader036/viewer/2022070317/5562c713d8b42aaf178b50cc/html5/thumbnails/13.jpg)
What can we do?
•Be an active commissioner
•Ensure contact at right level and make meetings productive for all
• Look for ways to best use skills and resources available
•Think beyond individual products
•Start talking13